Retrospective analysis of nanoparticle albumin-encapsulated paclitaxel versus dacarbazine in advanced melanoma

被引：0
|
作者：
Chalasani, P. [1 ]
Morgan, S. S. [1 ]
Butcher, D. [1 ]
Jeter, J. M. [1 ]
Hersh, E. [1 ]
Cranmer, L. D. [1 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e19002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19002
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
    Nanda, R.
    Chennamaneni, P.
    Gibson, J.
    Koetter, K.
    Libao, B.
    Skor, M.
    Maranville, J.
    Hoffman, P.
    Obeid, E.
    DiRienzo, A.
    Fleming, G.
    Conzen, S.
    CANCER RESEARCH, 2013, 73
  • [42] Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
    Patrick A. Ott
    Jason Chang
    Kathleen Madden
    Rajni Kannan
    Caroline Muren
    Crystal Escano
    Xin Cheng
    Yongzhao Shao
    Sandra Mendoza
    Alex Gandhi
    Leonard Liebes
    Anna C. Pavlick
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 183 - 191
  • [43] Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
    Ott, Patrick A.
    Chang, Jason
    Madden, Kathleen
    Kannan, Rajni
    Muren, Caroline
    Escano, Crystal
    Cheng, Xin
    Shao, Yongzhao
    Mendoza, Sandra
    Gandhi, Alex
    Liebes, Leonard
    Pavlick, Anna C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 183 - 191
  • [44] Efficacy and safety of nanoparticle albumin-bound paclitaxel compared with solvent-based paclitaxel in adjuvant therapy for breast cancer: A retrospective study
    Lv, Huina
    Hong, Yanyan
    Zhang, Yuting
    Li, Siyu
    Li, Bingbing
    Zhang, Mingjun
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [45] Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC
    Yoneshima, Yasuto
    Morita, Satoshi
    Ando, Masahiko
    Nakamura, Atsushi
    Iwasawa, Shunichiro
    Yoshioka, Hiroshige
    Goto, Yasuhiro
    Takeshita, Masafumi
    Harada, Toshiyuki
    Hirano, Katsuya
    Oguri, Tetsuya
    Kondo, Masashi
    Miura, Satoru
    Hosomi, Yukio
    Kato, Terufumi
    Kubo, Toshio
    Kishimoto, Junji
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Okamoto, Isamu
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1523 - 1532
  • [46] The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
    Xing, Puyuan
    Zhu, Yixiang
    Shan, Ling
    Chen, Sipeng
    Hao, Xuezhi
    Li, Junling
    ONCOTARGET, 2017, 8 (50) : 87442 - 87454
  • [47] A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer
    Nanda, Rita
    Stringer-Reasor, Erica M.
    Saha, Poornima
    Kocherginsky, Masha
    Gibson, Jean
    Libao, Bernadette
    Hoffman, Philip C.
    Obeid, Elias
    Merkel, Douglas E.
    Khramtsova, Galina
    Skor, Maxwell
    Krausz, Thomas
    Cohen, Ronald N.
    Ratain, Mark J.
    Fleming, Gini F.
    Conzen, Suzanne D.
    SPRINGERPLUS, 2016, 5
  • [48] A PILOT NEOADJUVANT STUDY OF SEQUENTIAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOLLOWED BY FEC IN ADVANCED BREAST CANCER
    Ohtani, S.
    Kochi, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Fujiwara, Y.
    Iwamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 127 - 127
  • [49] Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
    Hagiwara, Yuya
    Nakasya, Akio
    Matsumoto, Toshihiko
    Ikoma, Tatsuki
    Yamamoto, Yoshiyuki
    Kurioka, Yusuke
    Tsuduki, Takao
    Kajiwara, Takeshi
    Nishina, Tomohiro
    Yamashita, Natsumi
    Moriwaki, Toshikazu
    Hyodo, Ichinosuke
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 2769 - 2778
  • [50] Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel Versus FOLFIRINOX for Recurrent Pancreatic Cancer After Resection
    Taguchi, Hiroki
    Otsuka, Taiga
    Shimokawa, Mototsugu
    Arima, Shiho
    Hashimoto, Shinichi
    Ido, Akio
    Koga, Futa
    Ueda, Yujiro
    Nakazawa, Junichi
    Komori, Azusa
    Otsu, Satoshi
    Fukahori, Masaru
    Makiyama, Akitaka
    Honda, Takuya
    Shibuki, Taro
    Mizuta, Toshihiko
    Mitsugi, Kenji
    Nio, Kenta
    Ide, Yasushi
    Ureshino, Norio
    Shirakawa, Tsuyoshi
    ANTICANCER RESEARCH, 2021, 41 (07) : 3573 - 3582
12345